A-Type Cinnamon Procyanidin Oligomers Protect Against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Neurotoxicity in Mice Through Inhibiting the P38 Mitogen-Activated Protein Kinase/P53/BCL-2 Associated X Protein Signaling Pathway

被引:16
作者
Xu, Qi [1 ,2 ]
Chen, Ziyu [1 ]
Zhu, Borong [3 ]
Wang, Gaorui [1 ]
Jia, Qi [3 ]
Li, Yiming [3 ]
Wu, Xiaojun [1 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai Key Lab Compound Chinese Med, Minist Educ MOE,Key Lab Standardizat Chinese Med, Shanghai, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Sch Publ Hlth, Shanghai, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Sch Pharm, Shanghai, Peoples R China
基金
上海市自然科学基金; 中国国家自然科学基金;
关键词
flavonoids; Parkinson's disease; cinnamon procyanidin oligomers; animal model; neuroprotection; EPIGALLOCATECHIN GALLATE; DOPAMINERGIC-NEURONS; NLRP3; INFLAMMASOME; APOPTOSIS; KINASE; DISEASE; CELLS;
D O I
10.1093/jn/nxaa128
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Parkinson's disease (PD) is a common neurodegenerative disorder. Cinnamon procyanidin oligomers (CPOs) are flavonoids with many claimed health benefits. Objective: This study aimed to elucidate the neuroprotection of A-type CPOs (CPO-A) and the underlying mechanisms in cultured cell and animal models of PD. Methods: Thirty male mice (C57BL/6, 9-wk old) were assigned to 3 groups (n = 10), and were given daily gavage of saline [control and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) groups] or CPO-A (150 mg/kg, CPO-A group) during days 1-15 and daily intraperitoneal injections of saline (control group) or MPTP (20mg/kg; MPTP and MPTP+CPO-A groups) during days 11-15. After the motor behavior test, all mice were killed on day 16 to collect the substantia nigra (SN) for assaying the neuroprotective effects of CPO-A. SH-SY5Y cells were treated with 12.5 mu M CPO-A for 2 h or 3 activators of stress-related kinases (5-25 mu M) for 12-48 h followed by 1 mM 1-methyl-4-phenylpyridinium (MPP+) for assays of viability, morphology, and stress status. Results: Compared with the control, the MPTP treatment decreased (P < 0.05) locomotor activity by 21%, and tyrosine hydroxylase (TH) positive neurons by 55% and Th mRNA concentration by 51% in the SN. The CPO-A treatment attenuated or restored (P < 0.05) these changes and inhibited (P < 0.05) the MPTP-induced activation of P38 mitogen-activated protein kinase (P38MAPK) and P53, along with the downstream expression of BCL-2 associated X protein (BAX) in the SN. In SH-SY5Y cells, the CPO-A treatment blocked (P < 0.01) the MPP+-induced accumulation of intracellular reactive oxygen species and neurotoxicity. However, this protection was abolished (P < 0.05) by activators of the P38MAPK/P53/BAX pathway. Conclusion: CPO-A protected against MPP+-induced cytotoxicity in SH-SY5Y cells and MPTP-induced neurotoxicity in mice by regulating the P38MAPK/P53/BAX signaling. Our findings reveal a novel role and mechanism of a food flavonoid CPO-A in preventing neurodegeneration.
引用
收藏
页码:1731 / 1737
页数:7
相关论文
共 38 条
[1]  
[Anonymous], 2014, EVID BASED COMPL ALT
[2]   Role of Mitogen Activated Protein Kinase Signaling in Parkinson's Disease [J].
Bohush, Anastasiia ;
Niewiadomska, Grazyna ;
Filipek, Anna .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (10)
[3]   Procyanidins alleviates morphine tolerance by inhibiting activation of NLRP3 inflammasome in microglia [J].
Cai, Yang ;
Kong, Hong ;
Pan, Yin-Bing ;
Jiang, Lai ;
Pan, Xiu-Xiu ;
Hu, Liang ;
Qian, Yan-Ning ;
Jiang, Chun-Yi ;
Liu, Wen-Tao .
JOURNAL OF NEUROINFLAMMATION, 2016, 13
[4]   Natural Compounds for the Management of Parkinson's Disease and Attention-Deficit/Hyperactivity Disorder [J].
Carlos Corona, Juan .
BIOMED RESEARCH INTERNATIONAL, 2018, 2018
[5]   Immunosuppressive Effects of A-Type Procyanidin Oligomers from Cinnamomum tamala [J].
Chen, Liang ;
Yang, Yang ;
Yuan, Pulong ;
Yang, Yifu ;
Chen, Kaixian ;
Jia, Qi ;
Li, Yiming .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 2014
[6]   Histone Deacetylase 1 Plays an Acetylation-Independent Role in Influenza A Virus Replication [J].
Chen, Lin ;
Wang, Chengmin ;
Luo, Jing ;
Su, Wen ;
Li, Meng ;
Zhao, Na ;
Lyu, Wenting ;
Attaran, Hamidreza ;
He, Yapeng ;
Ding, Hua ;
He, Hongxuan .
FRONTIERS IN IMMUNOLOGY, 2017, 8
[7]   Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 [J].
Dorsey, E. R. ;
Constantinescu, R. ;
Thompson, J. P. ;
Biglan, K. M. ;
Holloway, R. G. ;
Kieburtz, K. ;
Marshall, F. J. ;
Ravina, B. M. ;
Schifitto, G. ;
Siderowf, A. ;
Tanner, C. M. .
NEUROLOGY, 2007, 68 (05) :384-386
[8]   Targeting ERK signaling pathway by polyphenols as novel therapeutic strategy for neurodegeneration [J].
Farzaei, Mohammad Hosein ;
Tewari, Devesh ;
Momtaz, Saeideh ;
Arguelles, Sandro ;
Nabavi, Seyed Mohammad .
FOOD AND CHEMICAL TOXICOLOGY, 2018, 120 :183-195
[9]   The Nuclear Translocation of Mitogen-Activated Protein Kinases: Molecular Mechanisms and Use as Novel Therapeutic Target [J].
Flores, Karen ;
Yadav, Suresh Singh ;
Katz, Arieh A. ;
Seger, Rony .
NEUROENDOCRINOLOGY, 2019, 108 (02) :121-131
[10]   P38 MITOGEN-ACTIVATED PROTEIN KINASE AND PARKINSON'S DISEASE [J].
He, Jianying ;
Zhong, Wenwen ;
Zhang, Ming ;
Zhang, Rongping ;
Hu, Weiyan .
TRANSLATIONAL NEUROSCIENCE, 2018, 9 (01) :147-153